Cayman Chemical’s Post

More study is needed to bring the potential medical benefits to light on the synergies between the compounds found in cannabis, according to a review of the research. “Understanding the intricate interplay between cannabinoids, terpenes, and flavonoids is paramount for realizing the full therapeutic benefits of cannabis.”   The entourage effect has been widely discussed, often in reference to the user experience, but medical patients are learning to look for the combination of cannabinoids and terpenes that help the condition for which they seek treatment. New compounds called flavorants may also bring benefits but require further study.  It would be in everyone’s interest to delve into all the possibilities, bringing to light potential new treatments.    #cannabisresearch  #cannabisscience  #cannabistesting https://lnkd.in/eZhJ5ar7

The development of clinical trials in the use of medical marijuana is a very broad and very current topic. We have more and more scientific evidence on which diseases cannabis has a therapeutic effect on. However, we still need to exchange experiences and education in the clinical use of medical marijuana and the preparation of drugs containing cannabinoids. Therefore, I would like to thank the #CannMED24 Scientific Committee for the invitation and the opportunity to participate in the conference. For another year in a row, I could listen and learn from the best specialists and practitioners. On June 14-15, the “Polish Herbal Committee" is organizing the conference, for the first time with a session entirely devoted to the cultivation and medical use of hemp. Thank you for inviting me to co-host this session and for the opportunity to give the lecture "Safety of using medical marijuana". Through such activities and initiatives, we build awareness and create reliable knowledge about the neuroprotective, anti-inflammatory and analgesic effects of hemp raw material. Let's do this! Treatment must be based on scientific evidence! #CannMed24, #Cannabis sp, #therapy and safety #Polish Herbal Committee

Biologics/ biosimilars are an increasingly important feature of the pharma sector and of healthcare budgets. In this article my colleague Kyriakos Fountoukakos and Violetta Meli consider how EU competition law - often forged in the context of competition between originator and generic pharmaceuticals - applies to biologics/biosimilars. #pharma #competitionlaw #antitrust

Submitting an IND is a huge milestone for any company. Set yourself up for success with the strategies in our latest blog post. https://lnkd.in/ggkGyvSV #ind #fdasubmissions #regulatoryoperations #ectd #regulatorystrategy #biotech #pharma #lifesciences

🎯ABUSES 🎯 🪂 ONE OF THE MOST FLAGRANT ABUSES OF TNCS POWER 🪂🧿 🧿 Arguably the one with the most serious effects on millions of the poor. 🥏 Deals with drugs 💊 medicine for the poor is big business for the rich, in many developing countries 20-30 percent of the health budgets is spent on drugs, most of them made by pharmaceutical TNCs. 🥏 How the companies promote their products and how LIBERALISATION hinders countries from pursuing a national drugs policy, which means the poor are denied access to low cost, locally made drugs.

The cannabis plant has been revered for its medicinal properties for thousands of years. Dating as far back as 2800 BC, cannabis was utilized to address a wide range of health conditions and was even documented in Emperor Shen Nung's ancient pharmacopoeia. Further research in the 1940s and 1950s delved into the exploration of individual cannabinoids, such as CBD. Nearly 80 years ago, significant strides were made in understanding these compounds. I've provided a link to this pioneering advancement. Although CBD itself is not a recent discovery, our innovation lies in the delivery system we offer. Our product, PICO IV, showcases a minuscule pico-sized cannabidiol molecule that effortlessly navigates the endocannabinoid system through intravenous treatments. We are excited to unlock the limitless potential of CBD with this groundbreaking therapy, which has generated widespread anticipation as a revolutionary solution. British Pharmacological Society publication: https://lnkd.in/ea7NNiNm #CBD #CBDIVtherapy #Cannabidiol #RevolutionaryTechnology #WhenScienceMeetsNature #Innovation #PicoIV

Join us for Part 2: CBD & THC: Understanding Key Components of Cannabis for Medical Use https://lnkd.in/dbrMhht7 Date: Tuesday, December 5, 2023 • Time: 1:00-2:00 PM ET Medical cannabis is legal in the majority of the United States and is increasingly available for adult recreational use. Clinicians need to be aware of the current evidence for cannabinoids for various conditions and symptoms, pharmacology, adverse effects, and potential contraindications as they will increasingly see patients using cannabis or cannabinoids more openly. This session will provide foundational knowledge of cannabidiol (CBD) and tetrahydrocannabinol (THC), how each cannabis component might be used by their patients, what the current effectiveness data suggest for conditions and symptoms, and pertinent monitoring parameters.

"A new federally funded study into the effects of cannabis terpenes suggests that the compounds could be 'potential therapeutics for chronic neuropathic pain,' finding that an injected dose of the compounds produced a 'roughly equal' reduction in pain markers when compared to a smaller dose of morphine. Terpenes also appeared to enhance the efficacy of morphine when given in combination. "Unlike with morphine, however, none of the studied terpenes produced a meaningful reward response, the research found, indicating that 'terpenes could be effective analgesics with no rewarding or dysphoric side effects.'” (Marijuana Moment) To find out if CBD or medical cannabis is right for you, call (386) 302-4842 and schedule a free consultation with our experts! #CoastalWellnessCenters #VolusiaCounty #Pain #ChronicPain #OrmondBeach #OrangeCity #DaytonaBeach #Therapy #QualifyingConditions #MedicalCannabis #CBD #THC #CannabisClinic #MedicalMarijuana #Cannabis #Marijuana

In Case You Missed It Read the latest article from Ruth Fisher, PhD, on the research on cannabis for COVID-19. An enormous body of research on cannabis—and cannabidiol (CBD) in particular—has shown cannabis to induce strong anti-viral and anti-inflammatory effects. It is still early days, so no clinical studies establishing the efficacy of cannabis for COVID-19 have yet been conducted, but studies have established several clear mechanisms of action for using cannabis to treat COVID-19. ➡️ Read the article for the full overview: https://ow.ly/9BGk50Rctmo

Join us for Part 2: CBD & THC: Understanding Key Components of Cannabis for Medical Use https://lnkd.in/eAVRxAfV Date: Tuesday, December 5, 2023 • Time: 1:00-2:00 PM ET Medical cannabis is legal in the majority of the United States and is increasingly available for adult recreational use. Clinicians need to be aware of the current evidence for cannabinoids for various conditions and symptoms, pharmacology, adverse effects, and potential contraindications as they will increasingly see patients using cannabis or cannabinoids more openly. This session will provide foundational knowledge of cannabidiol (CBD) and tetrahydrocannabinol (THC), how each cannabis component might be used by their patients, what the current effectiveness data suggest for conditions and symptoms, and pertinent monitoring parameters.